---
title: Mandatory notification of trade and disclosure of large shareholding
description: Mandatory notification of trade and disclosure of large shareholding
---

Vatne Equity AS, a closely related party of Runar Vatne, Board Member of Gentian  
Diagnostics ASA, has today purchased 100,000 shares in Gentian Diagnostics ASA  
at a price of NOK 67.2174 per share. After the transaction Vatne Equity AS and  
closely related parties of Runar Vatne owns 2,337,224 shares Gentian Diagnostics  
ASA corresponding to 15.17% of the outstanding shares and voting rights.

This information is subject to the disclosure requirements pursuant to MAR and  
Section 5-12 of the Norwegian Securities Trading Act and the Norwegian  
Securities Trading Act 4-2 as regards to the disclosure of large shareholding.

**More information:**  
[Access the news on Oslo Bors NewsWeb site](https://newsweb.oslobors.no/message/540725)

 

[  540725_GDASA - KRT-1500_Runar Vatne.pdf](https://live.euronext.com/sites/default/files/company_press_releases/announcements/540725_GDASA%20-%20KRT-1500_Runar%20Vatne.pdf)

### You may also read

[Jul 02, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-and-disclosure-of-large-shareholding#)

##### [Gentian Diagnostics: Invitation to presentation of second quarter results](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

[Jun 24, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-and-disclosure-of-large-shareholding#)

##### [ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

[May 29, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-and-disclosure-of-large-shareholding#)

##### [Mandatory notification of trade](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)